Parkinson's Disease Clinical Trials in Los Angeles

Showing 21-40 of 73 trials

Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation

NCT03047629

This is a Phase 1/2a study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of an orally-administered medication to relieve symptoms of constipation associated with Parkinson's Disease. Ten patients will be enrolled in Phase 1, and will be studied over an 8-12 week period. Forty patients will be enrolled in Phase 2, and will be studied over an 8-10 week period. All subjects will receive the study drug during one of the observational periods of the study.

Parkinson's DiseaseConstipation

Enterin Inc.50 participantsStarted May 2017

Los Angeles, California, United States • Englewood, Colorado, United States • Washington D.C., District of Columbia, United States +12 more locations

COMPLETEDPHASE3< 1 mile

Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

NCT02542696

An Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

Parkinson Disease

Sumitomo Pharma America, Inc.496 participantsStarted Aug 2015

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +67 more locations

Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation

Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

Parkinson's Disease Trials in Other Cities

Deep Brain Stimulation (DBS) for the Treatment of Parkinson's Disease

FitMi PD Home Therapy for Parkinson's Disease

Safety and Biomarker Study of PTC-589 in Participants With Parkinson's Disease

Study of Urate Elevation in Parkinson's Disease, Phase 3

A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness

Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia

Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)

An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease

Safety and Tolerability Study of K0706 in Subjects With Parkinson's Disease

Study to Evaluate DNL201 in Subjects With Parkinson's Disease

A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD)

Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease

A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease

Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide)

A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066

Nilotinib in Parkinson's Disease

Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease

A Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease

Other Conditions in Los Angeles